baber/WOPTO huggingface dataset:
Patent AU-2328192-A (AU)
Title: Process and device for the manufacture of a microporous membrane gel plate and gel cassette
IPC: G01N27/447
Filed: 1992-07-08
Abstract: PCT No. PCT/FR92/00650 Sec. 371 Date Feb. 23, 1993 Sec. 102(e) Date Feb. 23, 1993 PCT Filed Jul. 8, 1992 PCT Pub. No. WO93/01491 PCT Pub. Date Jan. 21, 1993.A method and apparatus for fabricating a microporous-membrane for gel plate separating and transferring macromolecules by electrophoresis, the apparatus comprising a peripheral frame (10) provided with a removable bottom plate and including means (54, 58, 60, 64) enabling the membrane to be tensioned after it has been placed on the liquid gel as cast onto the bottom plate.
Patent AU-2361484-A (AU)
Title: Benzoylurea compounds
Inventor: BROUWER MARIUS S
IPC: A01N47/34
Filed: 1984-01-19
Abstract: The invention relates to new benzoylurea compounds of the general formulawhereinR<sub>1</sub> is a halogen atom,R<sub>2</sub> is a hydrogen atom or a halogen atom,R<sub>3</sub> is a hydrogen atom or represents 1 or 2 substituents which are selected from the group consisting of chlorine, methyl and trifluormethyl,R<sub>4</sub> is a hydrogen atom or represents 1-3 substituents which are selected from the group consisting of halogen, and alkyl, alkoxy, haloalkyl and haloalkoxy, having 1-4 carbon atoms,X is N or CH,n is 0 or 1, andR<sub>5</sub> is a hydrogen atom, an alkyl group having 1-6 carbon atoms, an alkenyl group having 2-6 carbon atoms, or a cycloalkyl group having 3-6 carbon atoms, with the proviso, that, if n is 0 and R<sub>s</sub> is a hydrogen atom, R<sub>3</sub> is a hydrogen atom.The compounds have an -insecticidal and acaricidal activity. After having been processed to compositions, the compounds may be used for the control of insects and/or mites in a dosage of 1 to 5000 grams of active substance per hectare. In addition the compounds have an antitumor activity and may be used in pharmaceutical compositions.
Patent AU-2435499-A (AU)
Title: Method and system for accumulating call prepayment
Inventor: PLUSH CHRISTOPHER
IPC: H04W4/24
Filed: 1999-02-05
Abstract: Subscribers in a mobile communications system are provided with a bundle of call time each billing period, against which standard call types are rated. If, at the end of one billing period, a portion of the bundle for that billing period remains, the rating system associates the remaining portion with a bundle provided for the forthcoming billing period. In one embodiment, rating is interrupted whilst any remaining portions of the previous bundles are added to the newly-created bundles for the next period. In other embodiments, the rating system refers both to the current bundle and to a previous bundle when rating standard call types.
Patent AU-2440192-A (AU)
Title: Pipe joint and process for producing pipe joints made of polyolefin
IPC: B29K23/00
Filed: 1992-08-21
Abstract: A pipe end (13) of a pipe (12) consisting of polyolefin is deformed cold, that is to say at ambient temperature, with the aid of an expanding mandrel. Once the expanding mandrel has been withdrawn, the expanded pipe end (13) and a respectively desired connecting part, or the pipe end (11) of a further pipe (10), are plugged onto one another. The pipe end (13) consisting of polyolefin experiences only a reversible deformation and, as a result of it deforming back to its original shape, forms a firm, gas-tight connection to the connecting part or to the other pipe end (11). <IMAGE>
Patent AU-2444597-A (AU)
Title: Room temperature stable color center laser, lif:f2+** material, and method of lasing
Inventor: MIROV SERGEY B
IPC: C30B17/00
Filed: 1997-04-08
Abstract: The present invention is directed to a tunable, solid state laser utilizing room temperature, stable, color centers of LiF:F2+** material. Also disclosed is a method of lasing. An object of the present invention is to develop and optimize LiF:F2+** thermostabilized active media, to propose a method of pumping, and to realize a room temperature, stable and efficient operation of the color center laser. These and other objects are achieved by introducing special dopants in the crystal at the stage of crystal growing; applying special regimes of ionizing treatment of the crystal, resulting in thermostabilization of the F2+ centers in LiF crystals; and utilizing alexandrite laser radiation for color center crystal pumping with a pump radiation frequency which is appropriate for the selective excitation of the F2+ color centers. The invention can be used in cases when monochromatic laser emission tunable in the visible-infrared spectral region is required for solving problems in various fields of science and technology such as laser spectroscopy, photochemistry, photobiology, medicine, and the like.
Patent AU-2559000-A (AU)
Title: Combinations for the treatment of diseases involving angiogenesis
Inventor: DAVIS PETER DAVID
IPC: A61P35/00
Filed: 2000-02-15
Abstract: Compositions for the inhibition of the formation of new vasculature by angiogenesis are provided comprising the combination of a vasculature damaging agent and an inhibitor of the formation or action of nitric oxide in mammalian systems. There are also provided the use of said combinations in medicaments and kits of said compounds and treatment employing said materials.
Patent AU-2651888-A (AU)
Title: Polyphenol polymeric metal treatment compositions
Inventor: LINDERT ANDREAS
IPC: C08F8/32
Filed: 1988-12-05
Abstract: A metal treatment solution comprising an effective amount of a soluble or dispersible compound which is a derivative of a polyphenol. The present invention comprises novel derivatives of polyphenol compounds useful in the treatment of the surface of metal articles. The present invention also encompasses novel surface treatment solutions or dispersions, and methods of using these solutions or dispersions. The compositions of the present invention include amine oxide containing polyphenol compounds and derivatives thereof. The molecular weight of the polyphenols used in derivatives of the present invention have molecular weights of from about 360 to about 30,000 or greater. The resulting derivatives of the present invention typically have a molecular weight of up to about 2,000,000 with molecular weights within the range of about 700 to about 70,000 being preferred.
Patent AU-2661499-A (AU)
Title: Medical electrode
Inventor: HEARD STEVE
IPC: A61N1/04
Filed: 1999-02-08
Abstract: An electrode providing electrical contact with a patient's skin includes a conductive member (11) adapted for connection to an external electrical apparatus, a non-liquid film (15) for electrically interfacing to the patient's skin, the non-liquid film being electrically, and mechanically connected to the conductive member. The non-liquid film includes an electrically conductive organic polymer plasticized with a polyhydric alcohol with said organic polymer being derived from a monomeric mixture comprising from about 15 pph to 30 pph acrylic acid, 0.5 pph to 30 pph N-vinyl pyrrolidine and 0.01 pph to 2 pph of a crosslinking agent. The monomeric mixture may further comprise from about 0.5 pph to 8 pph of a thickening agent selected from the group consisting of N-vinyl pyrrolidine/acrylic acid copolymers and N-vinyl pyrrolidine/vinyl acetate.
Patent AU-2688301-A (AU)
Title: Sleeve comprising means for fixing printing plates and method for making same
Inventor: AUBANEL LAURENT
IPC: B41F30/00
Filed: 2000-12-20
Abstract: The invention concerns an endless sleeve comprising at least a substantially cylindrical support and whereof the outer surface is coated with at least a layer of bonding and permanently adhesive material. Said sleeve is designed to be mounted on a support cylinder, while its outer surface enables printing plates to be removably fixed by adhesion. The invention is applicable for flexographic printing.
Patent AU-2828792-A (AU)
Title: Packaging and dispensing system for fluid and semi-fluid cement admixtures
IPC: B28C5/00
Filed: 1992-11-12
Abstract: The present invention relates to a packaging and dispensing system especially suitable for semi-fluid or fluid cement admixtures (8). The admixture is encapsulated in a material (5,7), such as gelatin or wax, which ruptures, shatters, or disintegrates in the wet cementitious mixture during a period of mechanical mixing. The present invention also contemplates a method of modifying the properties of cementitious mixtures by adding thereto an encapsulated admixture in a predetermined amount sufficient to provide a modified cementitious composition having the desired properties.
Patent AU-2935395-A (AU)
Title: Non-coextrusion method of making multi-layer angioplasty balloons
Inventor: ROYCHOWDHURY SURANJAN
IPC: A61F2/958
Filed: 1995-07-31
Abstract: A non-coextrusion process for making multi-layer angioplasty balloons involves pre-forming separate parisons and then concentrically disposing the plural parisons to form a composite parison which is then subjected to a blow-molding process. The resulting balloon can have its properties tailored by appropriate selection of the particular plastics to be used for the multiple parisons.
Patent AU-2947700-A (AU)
Title: Height-adjustable support for supporting a table top
Inventor: WOLTERS JOHAN
IPC: A47B9/00
Filed: 2000-02-25
Abstract: Assembly comprising two height-adjustable supports such as for a table top, the supports at their upper ends being mutually connected by a beam. The height-adjustment takes place in that a threaded rod is rotatably received in the upper part and extends into a nut, fitted in the lower part of the support. At its upper end, the threaded rod is connected to a bevel gear wheel, which is in engagement with a bevel gear wheel connected to a coupling rod, coupling the threaded rods of both supports to each other. The lower part is led across the upper part, and a screening plate extending around the circumference of the support is connected to the upper part, the screening plate running downwards and abutting the inner circumference of a tubular part connected to the lower part of the support.
Patent AU-2968701-A (AU)
Title: Jak/stat pathway inhibitors and the uses thereof
Inventor: VASIOS GEORGE
IPC: A61P35/02
Filed: 2001-01-22
Abstract: The role of the JAK/STAT signal transduction pathway cellular mechanisms that lead to the onset and progression of degenerative joint diseases or disorders such as osteoarthritis (OA) is disclosed. Certain known effective OA therapeutics such as hymenialdisine, debromohymenialdisine, and its variants and derivatives are shown to function as JAK3-specific inhibitors, which downregulate steady state mRNA levels of key cellular components involved in cartilage degradation. Another JAK3-specific inhibitor, not previously known as an OA therapeutic, is shown to downregulate steady state mRNA levels of various cellular components involved in cartilage degradation in a manner identical to that of the known OA therapeutics.
Patent AU-3103200-A (AU)
Title: Instantaneous traffic monitoring system
Inventor: LANG BROOK
IPC: G08G1/123
Filed: 1999-11-23
Abstract: A system (10) for instantaneously monitoring traffic congestion including a plurality of monitoring electronic devices (20) located in motor vehicles (12) travelling on roadways (14-17) in a selected region (11). Each monitoring electronic device (20) is coupled to a GPS receiver (30) that provides physical location and to a wireless modem (24) capable of connecting to a wireless communication network (40). The system (10) also includes a central computer (60) connected to a wide area network (45) that is able to continuously download physical location information from a plurality of monitoring electronic devices (20) and non-monitoring devices (22) also connected to the wide area network (45). The central computer (60) uses a traffic monitoring software program (61) and a mapping database (65) containing roadway information for the region (11) and the movement information from the monitoring electronic devices (20) to create a continuously updated traffic congestion database (64). Authorized users of the system (10) are able to log onto the central computer (60) to obtain a portion of the traffic congestion database (64) for specific traffic flow and congestion information. Using the system (10), users are also able to obtain estimated times of arrival for a specific trip, and recommended alternative route information. The system (10) can also take into consideration current or anticipated events that may affect traffic congestion.
Patent AU-3316400-A (AU)
Title: A tear-off device for opening drink cans
Inventor: CAVALLO VINCENZO
IPC: B65D/
Filed: 2000-03-28
Abstract: A tear-off opening device for drink cans by means of a tab (1) with grip device (2) for tearing, comprising, underneath the tab (1), a shaped lamina (4), secured underneath the lid (6) for a segment (41) which partially surrounds the edge of the opening (3), whilst at least a remaining segment (42) stays free, the lamina (4) having a conformation that is able to vary from a first stable configuration in which, with the can closed, it is drawn up underneath the tab (1), to successive and transitory configurations that take place during the extraction of the lamina (4) through the opening (3) and to a final stable configuration in which, with the extraction completed, the lamina (4) constitutes a stable spout (8) with related opening (9) whose free edges belong to the free segment (42) of the lamina (4).
Patent AU-3318902-A (AU)
Title: Method for producing pectin hydrolysis products
Inventor: KUNZ MARKWART
IPC: A23L29/231
Filed: 2001-11-21
Abstract: Pectin hydrolysis products are produced by the two-stage hydrolysis of a pectin or pectin-containing plant material with pectin-hydrolysing enzymes. Production of pectin hydrolysis products comprises: (a) treatment of a pectin or pectin-containing plant material in aqueous solution or suspension with a pectin-hydrolysing enzyme (A); and (b) treatment of the product with a pectin-hydrolysing enzyme (B). The products obtained contain galacturonides with at least one 4,5-unsaturated galacturonic acid molecule and are esterified with methanol to >= 20%. An independent claim is also included for a pharmaceutical or dietetic preparation containing the pectin hydrolysis products and a carrier. ACTIVITY : Antibacterial. No data is given. MECHANISM OF ACTION : None given in the source material.
Patent AU-3455700-A (AU)
Title: Method for selectively separating blood cells by using lectin
Inventor: YURA HIROFUMI
IPC: G01N33/569
Filed: 2000-03-30
Abstract: The present invention provides a method for selective and high-yield separation, concentration, and recovery of desired cells from a blood sample. The method of the present invention is characterized in that the blood sample is caused to interact with lectins under conditions in which the cell membranes are inactive and cell-lectin complexes/non-complexes are formed, the sample containing these cell-lectin complexes/non-complexes is incubated together with a substrate, the surface of which is covered with polymers having carbohydrate chains which are specifically recognized by the lectins, and the cells are immobilized on the surface of the substrate via the lectins, and subsequently, the liquid layer and the solid phase are separated, and the desired blood cells are recovered from the liquid phase and/or the solid phase, and these lectins are present in such an amount that although the cells to be recovered from the solid phase bind to the solid phase with the polymer, the cells to be recovered from the liquid phase do not bind to the solid phase with the polymer.
Patent AU-3610195-A (AU)
Title: Large pillow-book
Inventor: BRETO JAVIER BARBED
IPC: B42D1/00
Filed: 1995-10-13
Abstract: Book Pillow formed by two pillows, one thick (1) and the other thin (2), united in a similar way to the covers of a book by a ribbon (3) sewn to the interior sides. The book Pillow has on the interior sides (4) the alphabet and a map of the world (7). Alternatively changeable leaves of fabric (3), are mounted between the pillows (1) and (2). <IMAGE>
Patent AU-3665901-A (AU)
Title: Novel human enzymes and polynucleotides encoding the same
Inventor: WALKE D WADE
IPC: C12N9/10
Filed: 2001-02-02
Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
Patent AU-3822002-A (AU)
Title: Layered manifold pressure swing adsorption device and method
Inventor: KEEFER BOWIE G
IPC: B01D53/06
Filed: 2001-09-25
Abstract: Rotary PSA systems, both axial and radial flow, with M > 1, provide interpenetrating, layered manifolds to accommodate all of the steps of a complex PSA cycle, suitable with equal compactness for any value of "M". This approach extends readily to accommodate a plurality of rotary PSA modules and their cooperating compression machinery within a single layered manifold assembly for a single PSA plant train. The rotary PSA apparatus includes stators that define fluid ports, which include PSA cycle sectors, each sector being defined by a light product delivery port, light product withdrawal ports, and light reflux return ports. Adsorber elements may directly contact one or more of the stators in a fluidly sealing manner. A PSA method uses the described apparatus and then supplies at least one feed fluid to pressurize an adsorber sets to substantially a higher pressure to initiate the PSA cycle.
Patent AU-3909497-A (AU)
Title: Anti-chlamydial methods and materials
Inventor: LAMBERT LEWIS H JR
IPC: A61K38/00
Filed: 1997-08-07
Abstract: The present invention relates to methods for treating chlamydial infection comprising administering to a subject suffering from a chlamydial infection a bactericidal/permeability-inducing (BPI) protein product.
Patent AU-3934999-A (AU)
Title: Phytosterol compositions
Inventor: WESTER INGMAR
IPC: A23L33/11
Filed: 1999-05-06
Abstract: This invention relates to phytosterols and phytostanols, in particular to fatty acid esters of phytosterols and phytostanols with a specified fatty acid composition. The invention further relates to methods for preparation of the phytosterol and phytostanol esters and their uses.
Patent AU-3944889-A (AU)
Title: Process for treating organic material
Inventor: PLESSIS JAH ABRAHAM DU
IPC: C05F7/00
Filed: 1989-08-09
Abstract: A process 10 for treating organic material comprises introducing ammonia or an ammonia based substance, via a flow line 32, into liquid organic material in a first zone of a pipe reactor 20, thereby to raise the pH of the material to at least 10, to form an organic material intermediate. The ammonia or ammonia based substance is allowed to react with the organic material intermediate for at least 5 minutes, and the temperature of the organic material intermediate is thereafter raised to at least 50 DEG C in a second zone by introducing phosphoric acid along a flow line 36, to produce treated organic material.
Patent AU-3972897-A (AU)
Title: Humanized immunoglobulin reactive with alpha4beta7 integrin
Inventor: PONATH PAUL D
IPC: C12P21/08
Filed: 1997-08-06
Abstract: The present invention relates to humanized immunoglobulins having binding specificity for ±4²7 integrin, comprising an antigen binding region of nonhuman origin (e.g., rodent) and at least a portion of an immunoglobulin of human origin (e.g., a human framework region, a human constant region). In one embodiment, the humanized immunoglobulin can compete with murine Act-1 for binding to human ±4²7 integrin. In a preferred embodiment, the antigen binding region of the humanized immunoglobulin comprises each of the complementarity determining regions of the light and heavy chains of the murine Act-1 antibody. The present invention further relates to a humanized immunoglobulin light chain or heavy chain, isolated nucleic acids comprising a sequence which encodes a humanized immunoglobulin or immunoglobulin chain of the present invention (e.g., a single chain antibody), constructs comprising a nucleic acid of the present invention, and host cells comprising a nucleic acid of the present invention useful in a method of preparing a humanized immunoglobulin. The humanized immunoglobulins can be used in diagnostic and therapeutic applications in humans, for example to control lymphocyte infiltration (including recruitment and/or accumulation) to mucosal tissue.
Patent AU-4129696-A (AU)
Title: Composition and method for enhancing electrotransport agent delivery
Inventor: HOLLADAY LESLIE A
IPC: A61N1/30
Filed: 1995-11-03
Abstract: An electrotransport device (10) for the electrotransport delivery of agents having at least one hydrophobic site thereon, such as peptides and proteins, contains donor and counter electrodes (12, 16 and 14, 18), a power source and electrical control circuitry (24). The donor electrode (12, 16) contains, in addition to the agent, an electrotransport enhancer such as non-ionic surfactants or zwitterionic surfactants without a net charge. A method of increasing electrotransport flux of agent shaving at least one hydrophobic site thereon utilizes non-ionic or zwitterionic surfactants in the solution or suspension containing the agent. A method for the electrotransport delivery of an agent with at least one hydrophobic site through a body surface relies on the incorporation of a non-ionic surfactant or a zwitterionic surfactant without a net charge, into the solution or suspension containing the agent to decrease its hydrophobicity.
Patent AU-4225299-A (AU)
Title: Insulin-like growth factor binding protein-3 variants
Inventor: MASCARENHAS DESMOND
IPC: C12N15/12
Filed: 1999-05-28
Abstract: The invention relates to variants of native insulin-like growth factor binding protein 3 (IGFBP-3). Variant IGFBP-3s are disclosed which are modified to be resistant to hydrolysis. Also disclosed are variant IGFBP-3s where the nuclear localization signal (NLS) in native IGFBP-3 is altered. Additionally, amino-terminally extended IGFBP-3s are disclosed which include a variety of N-terminal extensions, including peptide and nucleotide binding domains, specific binding members such as ligand binding domains from receptors or antigen binding domains from immunoglobins, and peptide and protein hormones and growth factors. N-terminally extended IGFBP-3s may comprise hydrolysis-resistant or NLS variant IGFBP-3s.
Patent AU-4291201-A (AU)
Title: A medicament and method for the production thereof
Inventor: ABIDOV MUSA TAZHUDINOVICH
IPC: A61K31/502
Filed: 2001-02-28
Abstract: The present invention can be used in medical practice specifically in chemical and pharmaceutical production of medicinal agents capable of modulating the immune system. This invention essentially relates to a new medicinal preparation 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt having immunomodulatory, antiinflammatory, and antioxidant properties. The preparation is obtained from 3-nitro-phthalanhydride by consecutive isolation of intermediate and end products. The intermediate products include 5-nitro-2,3-dihydrophthalazine-1,4-dione and 5-amino-2,3-dihydrophthala2ine-1,4-dione. The reaction between 5-amino-2,3-dihydrophthalazine-1,4-dione and sodium hydroxide yields the target product, 5-animo-2,3-dihydrophthalazine-1,4-dione sodium salt. The method allows to produce the medicinal preparation with high pharmaceutical activity. It is provided an example of application of this preparation.